Long-term in vivo biodistribution and toxicity of Gd(OH)3 nanorods

Biomaterials

Volumn 34, Issue 2, 2013, Pages 508-515

  Yang, Yang ^a   Sun, Yun ^a   Liu, Ying ^a   Peng, Juanjuan ^a   Wu, Yongquan ^a   Zhang, Yingjian ^a   Feng, Wei ^a   Li, Fuyou ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Biodistribution; Gd(OH)3; Long term toxicity; Nanorods; Single photon emission computed tomography (SPECT)

Indexed keywords

ACIDIC CONDITIONS; ADVERSE EFFECT; BIOCHEMICAL ANALYSIS; BIODISTRIBUTIONS; BODY WEIGHT; IN-VIVO; LONG-TERM RETENTION; LONG-TERM TOXICITY; MAGNETIC RESONANCE IMAGING CONTRAST AGENTS; NANORODS; RARE EARTH HYDROXIDE; SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY;

CONTRAST MEDIUM; GADOLINIUM; HYDROXIDE; NANOMATERIAL; NANOROD; SAMARIUM 153;

ACIDITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BODY WEIGHT; CONTROLLED STUDY; CYTOTOXICITY; HEART MUSCLE CELL; HEMATOLOGY; HISTOLOGY; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER CELL; LONG TERM CARE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TISSUE DISTRIBUTION;

ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; CONTRAST MEDIA; GADOLINIUM; HUMANS; HYDROXIDES; MAGNETIC RESONANCE IMAGING; MICE; NANOTUBES; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

MUS;

EID: 84868196662     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.09.075     Document Type: Article

References (49)

1. 4. IOP Conf Ser: Mater Sci Eng 2011, 23:012003.
2. Wang F., Liu X.G. Recent advances in the chemistry of lanthanide-doped upconversion nanocrystals. Chem Soc Rev 2009, 38:976-989.
3. Bogdan N., Vetrone F., Ozin G.A., Capobianco J.A. Synthesis of ligand-free colloidally stable water dispersible brightly luminescent lanthanide-doped upconverting nanoparticles. Nano Lett 2011, 11:835-840.
4. Wang L.Y., Yan R.X., Hao Z.Y., Wang L., Zeng J.H., Bao H., et al. Fluorescence resonant energy transfer biosensor based on upconversion-luminescent nanoparticles. Angew Chem Int Ed 2005, 44:6054-6057.
5. Yang P.P., Quan Z.W., Hou Z.Y., Li C.X., Kang X.J., Cheng Z.Y., et al. A magnetic, luminescent and mesoporous core-shell structured composite material as drug carrier. Biomaterials 2009, 30:4786-4795.
6. Achatz D.E., Meier R.J., Fischer L.H., Wolfbeis O.S. Luminescent sensing of oxygen using a quenchable probe and upconverting nanoparticles. Angew Chem Int Ed 2011, 50:260-263.
7. 4:Eu nanoparticles as versatile optical bioprobes. Adv Funct Mater 2010, 20:3708-3714.
8. Jiang S., Zhang Y. Upconversion nanoparticle-based FRET system for study of siRNA in live cells. Langmuir 2010, 26:6689-6694.
9. 3+ monodisperse nanocrystals. Nano Lett 2007, 7:847-852.
10. 3+ nanoparticles. Chem Mater 2009, 21:717-723.
11. Cao T.Y., Yang Y., Gao Y., Zhou J., Li Z.Q., Li F.Y. High-quality water-soluble and surface-functionalized upconversion nanocrystals as luminescent probes for bioimaging. Biomaterials 2011, 32:2959-2968.
12. 3+ nanocrystals. J Am Chem Soc 2009, 131:14200-14201.
13. 3+ (Ln = Yb, Er, Tm) nanocrystals. J Mater Chem 2011, 21:717-723.
14. Mai H.X., Zhang Y.W., Si R., Yan Z.G., Sun L.D., You L.P., et al. High-quality sodium rare-earth fluoride nanocrystals: controlled synthesis and optical properties. J Am Chem Soc 2006, 128:6426-6436.
15. 3+ (Ln = Er, Tm, Ho, Er/Tm, Tm/Ho) microstructures. J Mater Chem 2012, 22:10889-10899.
16. Yu M.X., Li F.Y., Chen Z.G., Hu H., Zhan C., Yang H., et al. Laser scanning up-conversion luminescence microscopy for imaging cells labeled with rare-earth nanophosphors. Anal Chem 2009, 81:930-935.
17. Xiong L.Q., Chen Z.G., Tian Q.W., Cao T.Y., Xu C.J., Li F.Y. High contrast upconversion luminescence targeted imaging in vivo using peptide-labeled nanophosphors. Anal Chem 2009, 81:8687-8694.
18. Hu H., Xiong L.Q., Zhou J., Li F.Y., Cao T.Y., Huang C.H. Multimodal-luminescence core-shell nanocomposites for targeted imaging of tumor cells. Chem Eur J 2009, 15:3577-3584.
19. 4 core-shell nanotubes. Chem Commun 2011, 47:8019-8021.
20. Steiner M.S., Duerkop A., Wolfbeis O.S. Optical methods for sensing glucose. Chem Soc Rev 2011, 40:4805-4839.
21. 3+ doped fluoride nanophosphors. Nano Lett 2008, 8:3834-3838.
22. Chatteriee D.K., Rufalhah A.J., Zhang Y. Upconversion fluorescence imaging of cells and small animals using lanthanide doped nanocrystals. Biomaterials 2008, 29:937-943.
23. Idris N.M., Li Z.Q., Ye L., Sim E.K.W., Mahendran R., Ho P.C.L., et al. Tracking transplanted cells in live animal using upconversion fluorescent nanoparticles. Biomaterials 2009, 30:5104-5113.
24. 3+ nanoparticles. J Alloys Compd 2012, 527:25-29.
25. Zhou J., Sun Y., Du X.X., Xiong L.Q., Hu H., Li F.Y. Dual-modality in vivo imaging using rare-earth nanocrystals with near-infrared to near-infrared (NIR-to-NIR) upconversion luminescence and magnetic resonance properties. Biomaterials 2010, 31:3287-3295.
26. 1 magnetic resonance imaging contrast agent. Adv Mater 2009, 21:4467-4471.
27. 4 nanocrystals. Adv Funct Mater 2009, 19:853-859.
28. Mack J., Kobayashi N. Low symmetry phthalocyanines and their analogues. Chem Rev 2010, 111:281-321.
29. Sun Y., Yu M.X., Liang S., Zhang Y.J., Li C.G., Mou T.T., et al. Fluorine-18 labeled rare-earth nanoparticles for positron emission tomography (PET) imaging of sentinel lymph node. Biomaterials 2011, 32:2999-3007.
30. 4 nanophosphors for multimodality PET/MR/UCL imaging. Biomaterials 2011, 32:1148-1156.
31. 18F-Labeled magnetic-upconversion nanophosphors via rare-earth cation-assisted ligand assembly. ACS Nano 2011, 5:3146-3157.
32. 3+ nanoprobe for CT and NIR-to-NIR fluorescent bimodal imaging. Biomaterials 2012, 33:5384-5393.
33. 4:Yb, Er/Tm nanostructure for MRI, CT and upconversion luminescence tri-modality imaging. Biomaterials 2012, 33:4618-4627.
34. 4-based upconversion nanophosphors for trimodality imaging of NIR-to-NIR upconversion luminescence, X-Ray computed tomography and magnetic resonance. Biomaterials 2012, 33:5394-5405.
35. 4 upconversion fluorescent nanocrystals. Biomaterials 2008, 29:4122-4128.
36. Cheng L., Yang K., Shao M.W., Lu X.H., Liu Z. In vivo pharmacokinetics, long-term biodistribution and toxicology study of functionalized upconversion nanoparticles in mice. Nanomedicine UK 2011, 6:1327-1340.
37. Xiong L.Q., Yang T.S., Yang Y., Xu C.J., Li F.Y. Long-term in vivo biodistribution imaging and toxicity of polyacrylic acid-coated upconversion nanophosphors. Biomaterials 2010, 31:7078-7085.
38. 3 nanorods for MR imaging with low toxicity. New J Chem 2012, 36:1335-1338.
39. Kryza D., Taleb J., Janier M., Marmuse L., Miladi I., Bonazza P., et al. Biodistribution study of nanometric hybrid gadolinium oxide particles as a multimodal SPECT/MR/Optical imaging and theragnostic agent. Bioconjug Chem 2011, 22:1145-1152.
40. Park J.-A., Kim J.Y., Kim H.-K., Lee W., Lim S.M., Chang Y., et al. Heteronuclear Gd-99mTc complex of DTPA-bis(histidylamide) conjugate as a bimodal MR/SPECT imaging probe. ACS Med Chem Lett 2012, 3:299-302.
41. Merkel O.M., Librizzi D., Pfestroff A., Schurrat T., Béhé M., Kissel T. In vivo SPECT and real-time gamma camera imaging of biodistribution and pharmacokinetics of siRNA delivery using an optimized radiolabeling and purification procedure. Bioconjug Chem 2008, 20:174-182.
42. Adam M.J., Wilbur D.S. Radiohalogens for imaging and therapy. Chem Soc Rev 2005, 34:153-163.
43. Bowen M.L., Orvig C. 99m-Technetium carbohydrate conjugates as potential agents in molecular imaging. Chem Commun 2008, 5077-5091.
44. Niers J.M., Chen J.W., Lewandrowski G., Kerami M., Garanger E., Wojtkiewicz G., et al. Single reporter for targeted multimodal in vivo imaging. J Am Chem Soc 2012, 134:5149-5156.
45. Pimlott S.L., Sutherland A. Molecular tracers for the PET and SPECT imaging of disease. Chem Soc Rev 2011, 40:149-162.
46. Bhushan K.R., Misra P., Liu F., Mathur S., Lenkinski R.E., Frangioni J.V. Detection of breast cancer microcalcifications using a dual-modality SPECT/NIR fluorescent probe. J Am Chem Soc 2008, 130:17648-17649.
47. 111In-labeled polymersomes. Bioconjug Chem 2012, 23:958-965.
48. Dobrovolskaia M.A., Aggarwal P., Hall J.B., McNeil S.E. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharmaceutics 2008, 5:487-495.
49. Alexis F., Pridgen E., Molnar L.K., Farokhzad O.C. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharmaceutics 2008, 5:505-515.